Hpgc Renmintongtai Pharmaceutical Corporation Class ASSE: 600829

Announcement on Convening the 2025 Annual and Q1 2026 Performance and Cash Dividend Briefing

· Issued by Hpgc Renmintongtai Pharmaceutical Corporation Class A via Shanghai Stock Exchange
Announcement on Convening the 2025 Annual and Q1 2026 Performance and Cash Dividend Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Hpgc Renmintongtai Pharmaceutical Corporation Class A

All Hpgc Renmintongtai Pharmaceutical Corporation Class A news releases